skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 53  for All Library Resources

Results 1 2 3 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones
Material Type:
Article
Add to My Research

Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones

Clinical journal of the American Society of Nephrology, 2013-11, Vol.8 (11), p.1960-1967 [Peer Reviewed Journal]

Copyright © 2013 by the American Society of Nephrology 2013 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.01760213 ;PMID: 23929928

Full text available

2
Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study
Material Type:
Article
Add to My Research

Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo‐Controlled Study

Journal of the American Heart Association, 2017-11, Vol.6 (11), p.n/a [Peer Reviewed Journal]

2017 The Authors and Takeda Pharmaceuticals. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.117.006683 ;PMID: 29102979

Full text available

3
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study
Material Type:
Article
Add to My Research

Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study

Arthritis research & therapy, 2018-05, Vol.20 (1), p.99-99, Article 99 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1593-0 ;PMID: 29848361

Full text available

4
The Impact of Label Changes (Boxed Warning) on Real-World Febuxostat Utilization in Patients with Gout: A Cross-Sectional Drug Utilization Study
Material Type:
Article
Add to My Research

The Impact of Label Changes (Boxed Warning) on Real-World Febuxostat Utilization in Patients with Gout: A Cross-Sectional Drug Utilization Study

Rheumatology and therapy., 2023-10, Vol.10 (5), p.1277-1295 [Peer Reviewed Journal]

The Author(s) 2023 ;2023. The Author(s). ;ISSN: 2198-6576 ;EISSN: 2198-6584 ;DOI: 10.1007/s40744-023-00581-x ;PMID: 37460856

Full text available

5
Reply
Material Type:
Article
Add to My Research

Reply

Arthritis & rheumatology (Hoboken, N.J.), 2016-10, Vol.68 (10), p.2564-2564 [Peer Reviewed Journal]

2016, American College of Rheumatology ;ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39768

Full text available

6
Reply
Material Type:
Article
Add to My Research

Reply

Arthritis & rheumatology (Hoboken, N.J.), 2016-10, Vol.68 (10), p.2564-2564 [Peer Reviewed Journal]

ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39768

Full text available

7
Reply
Material Type:
Article
Add to My Research

Reply

Arthritis & rheumatology (Hoboken, N.J.), 2016-10, Vol.68 (10), p.2564 [Peer Reviewed Journal]

2016, American College of Rheumatology ;ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39768

Full text available

8
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Material Type:
Article
Add to My Research

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

The New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974

Full text available

9
Impact of Febuxostat on Renal Function in Gout Patients With Moderate‐to‐Severe Renal Impairment
Material Type:
Article
Add to My Research

Impact of Febuxostat on Renal Function in Gout Patients With Moderate‐to‐Severe Renal Impairment

Arthritis & rheumatology (Hoboken, N.J.), 2016-08, Vol.68 (8), p.2035-2043 [Peer Reviewed Journal]

2016, American College of Rheumatology ;2016, American College of Rheumatology. ;ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39654 ;PMID: 26894653

Full text available

10
Reply
Material Type:
Article
Add to My Research

Reply

Arthritis & rheumatology (Hoboken, N.J.), 2016-10, Vol.68 (10), p.2564-2564 [Peer Reviewed Journal]

EISSN: 2326-5205 ;DOI: 10.1002/art.39768

Full text available

11
Reply
Material Type:
Article
Add to My Research

Reply

Arthritis & rheumatology (Hoboken, N.J.), 2016-10, Vol.68 (10), p.2564 [Peer Reviewed Journal]

EISSN: 2326-5205 ;PMID: 27273789

Full text available

12
A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder
Material Type:
Article
Add to My Research

A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2022-03, Vol.32 (2), p.98-106 [Peer Reviewed Journal]

Copyright Mary Ann Liebert, Inc. Mar 2022 ;Ann C. Childress et al. 2022; Published by Mary Ann Liebert, Inc. 2022 Ann C. Childress et al. ;ISSN: 1044-5463 ;EISSN: 1557-8992 ;DOI: 10.1089/cap.2021.0138 ;PMID: 35230142

Full text available

13
Cardiovascular Safety of Febuxostat
Material Type:
Article
Add to My Research

Cardiovascular Safety of Febuxostat

The New England journal of medicine, 2018-10, Vol.379 (16), p.1582-1584 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc1809736 ;PMID: 30332566

Full text available

14
METHODS FOR CONCOMITANT TREATMENT OF THEOPHYLLINE AND FEBUXOSTAT
Material Type:
Patent
Add to My Research

METHODS FOR CONCOMITANT TREATMENT OF THEOPHYLLINE AND FEBUXOSTAT

Digital Resources/Online E-Resources

15
The effects of xanthine oxidase inhibition by febuxostat on the pharmacokinetics of theophylline
Material Type:
Article
Add to My Research

The effects of xanthine oxidase inhibition by febuxostat on the pharmacokinetics of theophylline

International journal of clinical pharmacology and therapeutics, 2012-05, Vol.50 (5), p.331-337 [Peer Reviewed Journal]

ISSN: 0946-1965 ;DOI: 10.5414/CP201648 ;PMID: 22541837

Full text available

16
Methods of treatment and compositions with xanthine oxidase inhibitors
Material Type:
Patent
Add to My Research

Methods of treatment and compositions with xanthine oxidase inhibitors

Digital Resources/Online E-Resources

17
Drug Interaction Studies with Dexlansoprazole Modified Release (TAK-390MR), a Proton Pump Inhibitor with a Dual Delayed-Release Formulation: Results of Four Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Studies
Material Type:
Article
Add to My Research

Drug Interaction Studies with Dexlansoprazole Modified Release (TAK-390MR), a Proton Pump Inhibitor with a Dual Delayed-Release Formulation: Results of Four Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Studies

Clinical drug investigation, 2009, Vol.29 (1), p.35-50 [Peer Reviewed Journal]

Adis Data Information BV 2009 ;Copyright Wolters Kluwer Health Adis International 2009 ;ISSN: 1173-2563 ;EISSN: 1179-1918 ;DOI: 10.2165/0044011-200929010-00004 ;PMID: 19067473

Full text available

18
Methods for concomitant treatment of theophylline and febuxostat
Material Type:
Patent
Add to My Research

Methods for concomitant treatment of theophylline and febuxostat

Digital Resources/Online E-Resources

19
Methods of treatment and compositions with xanthine oxidase inhibitors
Material Type:
Patent
Add to My Research

Methods of treatment and compositions with xanthine oxidase inhibitors

Digital Resources/Online E-Resources

20
METHODS FOR CONCOMITANT TREATMENT OF THEOPHYLLINE AND FEBUXOSTAT
Material Type:
Patent
Add to My Research

METHODS FOR CONCOMITANT TREATMENT OF THEOPHYLLINE AND FEBUXOSTAT

Digital Resources/Online E-Resources

Results 1 - 20 of 53  for All Library Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (16)

Refine My Results

Creation Date 

From To
  1. Before 2009  (4)
  2. 2009 To 2012  (9)
  3. 2013 To 2015  (18)
  4. 2016 To 2019  (21)
  5. After 2019  (2)
  6. More options open sub menu

Resource Type 

  1. Patents  (37)
  2. Articles  (16)
  3. More options open sub menu

Language 

  1. English  (50)
  2. French  (11)
  3. Chinese  (4)
  4. Spanish  (4)
  5. Portuguese  (2)
  6. German  (2)
  7. Japanese  (1)
  8. Korean  (1)
  9. More options open sub menu

Searching Remote Databases, Please Wait